Comment on

• Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

  Galanello R, Piga A, Forni GL, Bertrand Y, Foschini ML, Bordone E, Leoni G, Lavagetto A, Zappu A, Longo F, Maseruka H, Hewson N, Sechaud R, Belleli R, Alberti D. Galanello R, et al. Haematologica. 2006 Oct;91(10):1343-51. Haematologica. 2006. PMID: 17018383 Clinical Trial.